Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy
Biologics: Targets and Therapy · 2019-05 · Volume 13 · 33-51
DOI: 10.2147/btt.s166310 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biologics: Targets and Therapy, 2019-05. Verfasst von Esteban Cruz und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, The University of Sydney, Sydney, NSW, Australia. Die Arbeit wurde bisher 121-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.
Zitieren
APA
Cruz, E., & Kayser, V. (2019). Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy. Biologics: Targets and Therapy, Volume 13, 33-51. https://doi.org/10.2147/btt.s166310
Vancouver
Cruz E, Kayser V. Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy. Biologics: Targets and Therapy. 2019;Volume 13:33-51. doi:10.2147/btt.s166310
BibTeX
@article{Cruz2019,
author = {Cruz, Esteban and Kayser, Veysel},
title = {Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy},
journal = {Biologics: Targets and Therapy},
year = {2019},
volume = {Volume 13},
pages = {33--51},
doi = {10.2147/btt.s166310}
}
EUVIMED